Journal of PharmTechNova
Short Name: JPTN• ISSN: 3139-9258• Peer-Reviewed Open Access
Hydroalcoholic Extraction of Cissus quadrangularis and In Vitro Evaluation of Antifungal Properties
Abstract
Cissus quadrangularis is a medicinal plant traditionally recognized for its therapeutic potential, yet its antifungal properties remain underexplored. The present study aimed to investigate the physicochemical characteristics, phytochemical composition, and in vitro antifungal activity of the hydroalcoholic extract of Cissus quadrangularis. Plant material was subjected to Soxhlet extraction using a hydroalcoholic solvent system (70% ethanol:30% water). Physicochemical evaluation demonstrated that the extract met acceptable quality standards, with slightly acidic pH, low moisture content, and minimal inorganic and siliceous impurities. The absence of foreign organic matter, heavy metals, and pesticide residues confirmed the purity and safety of the plant material. High alcohol- and water-soluble extractive values indicated efficient extraction of phytoconstituents. Preliminary phytochemical screening revealed flavonoids, phenolic compounds, tannins, saponins, glycosides, terpenoids, steroids, alkaloids, and carbohydrates, while proteins were absent, indicating enrichment of low-molecular-weight bioactive compounds. The antifungal potential of the extract was evaluated against Fusarium falciforme using the food poison method. The results demonstrated a concentration-dependent reduction in radial mycelial growth, with partial inhibition observed in extract-treated plates and the highest inhibition recorded at 10% extract concentration. Radial growth measured 6.6 cm (2.5%), 4.8 cm (5%), and 3.1 cm (10%), corresponding to approximately 17.5%, 40.0%, and 53.1% inhibition, respectively, compared with the control. Complete growth inhibition was observed only in the positive control (fluconazole), whereas the solvent control showed no antifungal effect. Overall, the study highlights the phytochemical richness and notable antifungal potential of Cissus quadrangularis as a promising natural source of antifungal agents.
Research Keywords & Fields
Export Citation
Generate ready-to-use citations in standard scientific formats
Cited References
- 01.
1. Ademe M. Immunomodulation for the Treatment of Fungal Infections: Opportunities and Challenges. Front Cell Infect Microbiol. 2020;10:469.
- 02.
2. Mudenda S. Global Burden of Fungal Infections and Antifungal Resistance from 1961 to 2024: Findings and Future Implications. Pharmacol & Pharm. 2024;15(04):81–112.
- 03.
3. Marino A, Calvo M, Trovato L, Scalia G, Gussio M, Consoli U, et al. Mucorales/Fusarium Mixed Infection in Hematologic Patient with COVID-19 Complications: An Unfortunate Combination. Pathogens. 2023;12(2):304.
- 04.
4. Shah DA, Pucci N, Infantino A. Regional and varietal differences in the risk of wheat seed infection by fungal species associated with fusarium head blight in Italy. Eur J Plant Pathol. 2005;112(1):13–21.
- 05.
5. Bryła M, Pierzgalski A, Zapaśnik A, Uwineza PA, Ksieniewicz-Woźniak E, Modrzewska M, et al. Recent Research on Fusarium Mycotoxins in Maize—A Review. Foods. 2022;11(21);3465.
- 06.
6. Dar RA, Shahnawaz M, Ahanger MA, Majid I ul. Exploring the Diverse Bioactive Compounds from Medicinal Plants: A Review. J Phytopharm. 2023;12(3):189–95.
- 07.
7. Bouyahya A, Guaouguaou FE, El Omari N, El Menyiy N, Balahbib A, El-Shazly M, et al. Anti-inflammatory and analgesic properties of Moroccan medicinal plants: Phytochemistry, in vitro and in vivo investigations, mechanism insights, clinical evidences and perspectives. J Pharm Anal. 2022;12(1):35–57.
- 08.
8. Garg J, Ghoshal G, Bhadada SK, Katare OP. Derivatisation mechanistic-guided identification of phytoconstituents of different extracts of Cissus quadrangularis by TLC and standardization by HPTLC. Phytomedicine Plus. 2024;4(3):100601.
- 09.
9. Ranganathan S, Ganapathy D, Shanmugam R, Murthykumar K, Sekaran S. Osteogenic Potential of Cissus Quadrangularis: A Systematic Review. Texila Int J Public Heal. 2025;13(1).
- 10.
10. Farjana HN, Valiathan GM, Mohanasatheesh S. In-silico study on biomolecules derived from Cissus quadrangularis towards anti-inflammation. J Genet Eng Biotechnol. 2025;23(4):100571.
- 11.
11. Siddiqui FA, Bakshi V. Hydroalcoholic Extraction, Phytoconstituent Profiling by LC-HRMS, and Computational Analysis of Lantana Camara as Potential Glucokinase, Alpha Amylase, Alpha Glucosidase, and DPP-IV Inhibitors. Chem Methodol. 2025;9(12):1189–220.
- 12.
12. Sruthi V, Shankar Rao GB. Extraction, Phytochemical Screening, and Isolation of Active Fraction of Turnera ulmifolia Linn. Asian J Green Chem. 2024;8(4):411–26.
- 13.
13. Khan SL, Bakshi V. LC-HRMS and In Silico Analysis of Ailanthus excelsa Metabolites Targeting EGFR Triple Mutation (L858R/T790M/C797S). Adv J Chem Sect A. 2026;9(2):292–311.
- 14.
14. Chinala KM, Chaithanya A, Sawrov M, Sahithi A, Achyuth C. Phytochemical and Antimicrobial Evaluation of Laurus nobilis Leaves Against Acne and Dandruff-Causing Microorganisms. J Pharm Sci Comput Chem. 2025;1(1):50–7.
- 15.
15. Priyadarsini SS, Meenaxshi C. Pharmacognostic and phytochemical investigation of the aerial parts of Cissus quadrangularis Linn. J Sci Innov Res. 2013;2(5):872–9.
- 16.
16. Cho M, Lee J, Jang H, Doo M, Ha JH, Lee HJ. Physicochemical Properties and Sensory Evaluation of Yanggaeng with Alternative Sweeteners and Cissus quadrangularis Powder. Appl Sci. 2026;16(1):44.
- 17.
17. Ukwubile CA, Mathias SN, Pisagih PS. Acute and Subchronic Toxicity Evaluation and GC-MS Profiling of Ajumbaise: A Traditional Nigerian Polyherbal Formulation for Labor Enhancement and Pain Relief. J Pharm Sci Comput Chem. 2025;1(2):154–73.
- 18.
18. Jeenu J, Mathews SM. Pharmacognostical Studies on Stems of Clerodendrum infortunatum L. J Drug Deliv Ther. 2025;15(5):17–22.
- 19.
19. Barus BR, Sitorus P, Masfria. Assessment of physicochemical properties and phytochemical constituents along with antibacterial potential of Tarenna polycarpa leaf fractions. Asian J Pharm Clin Res. 2018;11(4):78–80.
- 20.
20. Erhonyota C, Edo GI, Onoharigho FO. Comparison of poison plate and agar well diffusion method determining the antifungal activity of protein fractions. Acta Ecol Sin. 2023;43(4):684–9.
- 21.
21. Lakhdari W, Benyahia I, Bouhenna MM, Bendif H, Khelafi H, Bachir H, et al. Exploration and Evaluation of Secondary Metabolites from Trichoderma harzianum: GC-MS Analysis, Phytochemical Profiling, Antifungal and Antioxidant Activity Assessment. Molecules. 2023;28(13):5025.
- 22.
22. Khan S, Kale M, Siddiqui F, Nema N. Novel pyrimidine-benzimidazole hybrids with antibacterial and antifungal properties and potential inhibition of SARS-CoV-2 main protease and spike glycoprotein. Digit Chinese Med. 2021;4(2):102–19.
Suggested & Related Publications
Articles in related pharmaceutical, biomedical, and life sciences research on PharmSciGate
Green Chemistry-Based Extraction, Phytochemical Screening, and Evaluation of Anti-Inflammatory Activity of Aerva lanata
Alshahrani, Malath Saeed; Alshahrani, Wajan Khalid; A Assiri, Sara Abdullah; Alasmari, Waad Oudah; Alqahtani, Arwa Ali
Green chemistry has emerged as an important approach in natural product research because it promotes environmentally friendly extraction techniques and minimizes the use of hazardous solvents. The present study investigated the green chemistry-based extraction, phytochemical screening, (PS) and evaluation of the anti-inflammatory activity of Aerva lanata, a medicinal plant widely used in traditional medicine. The plant material was collected from the Buldhana region of Maharashtra, India, shade-dried, powdered, and subjected to hydroalcoholic extraction using the maceration method to obtain the crude extract. Preliminary PS was performed using standard qualitative tests, which revealed the presence of several important phytoconstituents including alkaloids, flavonoids, phenolic compounds, tannins, saponins, terpenoids, and steroids, while glycosides were present in minor amounts. These phytochemicals are known for their significant pharmacological activities, particularly antioxidant and anti-inflammatory effects. The anti-inflammatory potential of the extract was evaluated using an in vitro protein denaturation inhibition assay at concentrations of 100–500 µg/mL. The results demonstrated a concentration-dependent increase in inhibition, with values of 10.4%, 15.8%, 17.6%, 28.9%, and 39.7% at concentrations of 100, 200, 300, 400, and 500 µg/mL, respectively. In comparison, the standard drug diclofenac sodium exhibited inhibition values of 40.2%, 55.6%, 69.4%, 82.1%, and 91.5% at the same concentrations. These findings indicate that Aerva lanata possesses notable AI, which may be attributed to the synergistic effects of its phytochemical constituents. Overall, the study supports the traditional medicinal use of Aerva lanata and highlights its potential as a promising natural source for developing safer anti-inflammatory therapeutic agents
Ultrasound-Assisted Extraction, Quality Assessment, and DPP-IV Inhibitory Activity of Cissus verticillata Hydroalcoholic Extract
Ganjare, Kedar Kailas; Tayade, Sharad D.; Tamboli, Arfin S.; Shaikh, Inzamamul Haq Ameer; Borkar, Vijay S.; Khedekar, Jyoti Bhushan
Cissus verticillata is a medicinal plant rich in bioactive phytoconstituents with promising therapeutic potential, particularly against diabetes. The present study aimed to evaluate the physicochemical characteristics, phytochemical composition, microbial quality, and in vitro dipeptidyl peptidase-IV (DPP-IV) inhibitory activity of the hydroalcoholic extract of Cissus verticillata. The whole herb was extracted using Ultrasound-assisted extraction (UAE) with a hydroalcoholic solvent (ethanol, 70:30 v/v). The obtained extract was characterized for organoleptic properties, physicochemical parameters, microbial quality, and qualitative phytochemical constituents using standard pharmacopeial methods. The antidiabetic potential was assessed by a chromogenic DPP-IV inhibition assay using sitagliptin as the reference standard. The hydroalcoholic extract exhibited a yield of 9.2% with satisfactory organoleptic characteristics. Physicochemical analysis demonstrated acceptable pH (7.2 and 6.1), low moisture content (4.9%), minimal foreign matter (0.5%), appropriate ash values, higher water-soluble extractive value (25.25%) than alcohol-soluble extractive value (19.35%), and the absence of heavy metals and pesticide residues. Microbiological evaluation confirmed the absence of Escherichia coli, Salmonella spp., Shigella spp., Pseudomonas aeruginosa, and Staphylococcus aureus. Preliminary phytochemical screening revealed abundant alkaloids, phenolic compounds, and flavonoids, along with carbohydrates, proteins, amino acids, glycosides, saponins, and tannins. The extract exhibited concentration-dependent DPP-IV inhibition, increasing from 18.33 ± 1.52% at 10 µg/mL to 82.00 ± 1.00% at 200 µg/mL, with an IC₅₀ of approximately 70 µg/mL. Overall, the hydroalcoholic extract of Cissus verticillata demonstrated satisfactory quality, safety, a rich phytochemical profile, and promising antidiabetic potential, supporting its further investigation as a natural source for the development of phytopharmaceuticals against diabetes.
In Vitro Antifungal Evaluation of a Posaconazole-Loaded Menthosomal Hydrogel Against Candida albicans
Bhosale, Namita Subhanrao; Upadhyay, Dinesh Kumar; Jagtap, Vijay Arjun
Posaconazole is a broad-spectrum triazole antifungal agent used against a range of pathogenic fungi. The present study aimed to evaluate the in vitro antifungal activity of an optimized Posaconazole-loaded Menthosomes hydrogel (PMLH) against Candida albicans. The antifungal activity was assessed using the agar well diffusion method, with the zone of inhibition (ZOI) used as the primary response. The optimized PMLH formulation was evaluated in comparison with a marketed Posaconazole formulation and Posaconazole active pharmaceutical ingredient (API). A drug-free hydrogel base and blank well were included as controls to determine the contribution of the formulation matrix and experimental setup to the observed antifungal activity. The optimized PMLH contained 90.20 ± 0.6% drug content and was tested at an equivalent Posaconazole concentration of 10 µg/mL. Following incubation, the ZOI was measured in millimetres. The PMLH exhibited a ZOI of 26.9 ± 1.7 mm, compared with 24.4 ± 1.5 mm for the marketed Posaconazole formulation and 18.8 ± 1.3 mm for Posaconazole API. No visible inhibition was observed for either the drug-free hydrogel base or blank. The larger inhibition zone produced by PMLH indicates enhanced apparent antifungal activity under the conditions of the agar diffusion assay and may be associated with improved drug dispersion and diffusion from the Menthosomal hydrogel matrix. However, the observed ZOI is also influenced by formulation viscosity, drug release, partitioning, and diffusion. Overall, the findings support the potential of PMLH as a promising formulation approach for improving the apparent antifungal performance of Posaconazole against C. albicans. Further standardized studies are warranted to confirm these findings.
Full-Text Access
Journal of PharmTechNova
A platform for pioneering research in novel pharmaceutical technology, biotechnology, drug delivery, clinical translation, and computational design.
This peer-reviewed publication is indexed directly from the publisher repository adhering to Open Archives Initiative (OAI-PMH) metadata standards, Crossref DOI schema, and Google Scholar Highwire Press protocols.